Psyence Biomedical to consolidate shares in bid to keep Nasdaq listing
The consolidation follows Psyence’s March debut on the Nasdaq through a SPAC merger with Newcourt Acquisition.
The post Psyence Biomedical to consolidate shares in bid to keep Nasdaq listing appeared first on Green Market Report.
